Study to Assess the Tolerability and the Safety of the Transition From Inhaled Treprostinil to Oral Selexipag in Patients With Pulmonary Arterial Hypertension
Clinical trial NCT02471183 · COMPLETED
Trial details
- NCT number
- NCT02471183
- Sponsor
- Actelion
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-12
- Primary completion
- 2016-12-05
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.